GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst. Despite being a “re-accelerating high-growth, high-margin company,” the stock was trading at a discount both to its peers and its historical average, according to KeyBanc Capital Markets. The GoodRx Holdings Club Analyst: Scott Schoenhaus upgraded the rating for GoodRx Holdings to Overweight while revising the price target to $9. The GoodRx Holdings Club Thesis: Signs of the company’s app downloads have been “encouraging,” having accelerated in February and remaining ...